CN Patent

CN121318878A — 基于“古德”缓冲液的阳离子脂质

Assigned to Translation Bio Co · Expires 2026-01-13 · 0y expired

What this patent protects

本发明部分提供了式(I)和其子式的第二代基于“古德”缓冲液的阳离子脂质：(I)，或其药学上可接受的盐。本文提供的化合物可例如作为脂质体递送媒介物的组分用于mRNA和所编码蛋白质的递送和表达，并且因此可用于治疗各种疾病、障碍和病症，如与一种或多种蛋白质的缺乏相关的那些。

USPTO Abstract

本发明部分提供了式(I)和其子式的第二代基于“古德”缓冲液的阳离子脂质：(I)，或其药学上可接受的盐。本文提供的化合物可例如作为脂质体递送媒介物的组分用于mRNA和所编码蛋白质的递送和表达，并且因此可用于治疗各种疾病、障碍和病症，如与一种或多种蛋白质的缺乏相关的那些。

Drugs covered by this patent

Patent Metadata

Patent number
CN121318878A
Jurisdiction
CN
Classification
—
Expires
2026-01-13
Drug substance claim
No
Drug product claim
No
Assignee
Translation Bio Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.